BiotechTube
Home/Lyterian Therapeutics/Michele (Michi) Rapé, Ph.D.
M(

Michele (Michi) Rapé, Ph.D.

Scientific Founder

Lyterian Therapeutics

Therapeutic Areas

NeuroscienceRare Disease

Lyterian Therapeutics Pipeline

DrugIndicationPhase
UndisclosedNeuroscience & Rare Disease FocusDiscovery

Leadership Team at Lyterian Therapeutics

AG
Aaron Gitler, Ph.D.
Scientific Founder
RT
Robert Tjian, Ph.D.
Scientific Founder
MW
Marius Wernig, M.D., Ph.D.
Scientific Founder
IW
Ingrid Wertz, Ph.D.
Scientific Founder
View full Lyterian Therapeutics profile